Clinical Trial Update: Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for preemptive therapy in high-risk chronic lymphocytic leukemia (Stage A); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Chronic Lymphoid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING